- Recent Funding
- Investors
- Agati Capital
Agati Capital portfolio
Agati Capital has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is Aravax's $42M Series B+ round in January 2024, alongside Novartis Venture Fund, Breakthrough Victoria, UniSuper and 1 other. That company is in Health and bio.
What Agati Capital invests in
- Health and bio · 1 · 100%
- Commerce and retail · 1 · 100%
- Consumer and social · 1 · 100%
How Agati Capital invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $42M |
Agati Capital portfolio companies
| Company | Round with Agati Capital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $42M | $62M | Jan 23, 2024 Series B+ |
Most frequent co-investors
NNovartis Venture Fund1 shared round · last Jan 23, 2024
UUniseed1 shared round · last Jan 23, 2024
UUniSuper1 shared round · last Jan 23, 2024
BBreakthrough Victoria1 shared round · last Jan 23, 2024
Similar investors
- EExar North Group1 company · 1 deal in 12 mo
CConsumer Collective by Atrium4 companies · 2 deals in 12 mo
GG20 Ventures4 companies · 2 deals in 12 mo
EElevar Equity4 companies · 1 deal in 12 mo
SSlauson & Co.5 companies · 5 deals in 12 mo
SStellaris Venture Partners5 companies · 4 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Agati Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Agati Capital, which is a subset of its real portfolio. API: /api/v1/investors/agati-capital (get a free API key). More: the most active VC firms and new venture capital funds.